U.S. Biotech Stock News

President Trump has threatened to destroy Iran's critical energy infrastructure, heightening geopolitical tensions. This raises the risk of a global energy supply shock that could affect large energy and infrastructure projects. Caterpillar (NYSE:CAT) has significant exposure to global energy infrastructure investments and international markets. Caterpillar, through its energy and transportation segments, supplies equipment used across power generation, oil and gas, and large infrastructure...

Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks requires a focus on companies with strong innovation potential and robust financial health that can capitalize on long-term trends despite short-term fluctuations.

The United States market has experienced a 3.5% decline over the past week, yet it remains up by 14% over the last year, with earnings projected to grow by 15% annually. In this context, finding stocks that may be trading below their estimated value can offer potential opportunities for investors seeking to capitalize on long-term growth prospects amidst fluctuating market conditions.

Klarna Group (NYSE:KLAR) has expanded its payment partnerships across travel, retail, and automotive parts. New and extended deals include EuroParcs in European travel, H&M in Romania and Hungary, and car parts retailer B-Parts. These agreements broaden Klarna's merchant network and extend its flexible, interest free installment options into new regions and sectors. Klarna Group, trading at $12.48, is adding fresh operational momentum through these partnerships at a time when the share...

Chefs' Warehouse (CHEF) has drawn investor attention after a monthly return of about an 18% decline, contrasting with an 8% gain over the past year, prompting a closer look at its current valuation and fundamentals. See our latest analysis for Chefs' Warehouse. Despite the recent 18% monthly share price return decline and a 5.8% 90 day share price return decline, Chefs' Warehouse still shows an 8.1% 1 year total shareholder return and an 86.1% 5 year total shareholder return, suggesting...

Over the last 7 days, the United States market has experienced a 3.5% drop, yet it has risen by 14% over the past year with earnings projected to grow by 15% annually in the coming years. In this environment, growth companies with high insider ownership can be particularly appealing as they may align management's interests with shareholders and potentially drive significant earnings growth.

Over the last 7 days, the U.S. market has dropped 3.5%, but it has risen by 14% over the past year, with earnings forecasted to grow annually by 15%. Investing in penny stocks — a term that may feel outdated yet remains relevant — can still provide access to growth opportunities, especially within smaller or newer companies. By focusing on those with robust financials and clear growth potential, investors can uncover valuable opportunities among these lesser-known stocks.

Over the last 7 days, the United States market has dropped 3.5%, yet it has seen a robust rise of 14% over the past year, with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying stocks with strong fundamentals and growth potential can be key to uncovering undiscovered gems worth exploring in March 2026.

Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year with earnings anticipated to grow by 15% annually in the coming years. In this fluctuating environment, dividend stocks that offer substantial yields can provide a reliable income stream and potential stability for investors seeking consistent returns amidst market volatility.

The recent 10% drop in Candel Therapeutics, Inc.'s ( NASDAQ:CADL ) stock could come as a blow to insiders who purchased...

Insiders who purchased Vera Bradley, Inc. ( NASDAQ:VRA ) shares in the past 12 months are unlikely to be deeply...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

If you are wondering whether Air Products and Chemicals at around US$291.56 is offering good value right now, this breakdown will help you assess how its current price compares with several valuation checks. The stock has recently been moving, with returns of 4.6% over the last 7 days, 5.8% over the last 30 days, 16.4% year to date, and 1.5% over the past year. Recent coverage has focused on Air Products and Chemicals as a major player in industrial gases, particularly its role in supplying...

Tripadvisor (TRIP) has drawn investor attention after recent share price moves, with the stock up about 3% over the past week but showing a decline of roughly 29% over the past 3 months. See our latest analysis for Tripadvisor. The recent 7-day share price return of 3.49% sits against a 90-day share price decline of 29.03% and a 1-year total shareholder return decline of 26.68%, which suggests short-term momentum is stabilising after a weaker longer-term trend. If this kind of setup has you...

Goosehead Insurance (NasdaqGS:GSHD) has appointed Martin Thornthwaite as General Counsel and Corporate Secretary. Thornthwaite succeeds John O’Connor, whose departure prompted the leadership change in the company’s top legal role. The move affects oversight of legal, governance, and regulatory matters at Goosehead Insurance. For investors watching Goosehead Insurance at a share price of $42.3, this change comes after a period of pressure on the stock. The company’s shares have seen a 22.0%...

Wondering if Mirum Pharmaceuticals at around US$87.90 is still offering value after a strong run, or if most of the opportunity is already reflected in the price. The stock has been flat over the past week, recorded a 4.8% decline over the last 30 days, yet is up 12.6% year to date and 99.6% over the past year, with a very large 3 year gain of 252.3% and a 5 year gain of 340.6%. Recent coverage has focused on Mirum Pharmaceuticals as a fast moving biotech name. This helps frame why the share...

H&R Block (HRB) is back in focus after recent share performance data showed a 3.3% gain over the past month, compared with a 27.3% decline over the past 3 months and a 40.1% drop over the past year. See our latest analysis for H&R Block. That mix of a 3.3% 1 month share price return alongside a 27.4% 3 month decline, with a 40.2% 1 year total shareholder return loss, points to fading momentum and shifting sentiment around H&R Block’s risk and growth profile. If this kind of reset has you...

The Morning Bull - US Market Morning Update Tuesday, Mar, 31 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 and Nasdaq-100 contracts up around 0.8%, as investors balance relief over interest rates with fresh worries about energy costs. The US 10 year Treasury yield sits near 4.32% after comments from the Federal Reserve suggested inflation expectations remain in check, which helps keep borrowing costs for mortgages, car loans and companies from climbing more...

If you are wondering whether Boston Scientific at around US$62.93 still offers value, the key question is how its current price lines up with the cash flows and assets you are actually paying for. The stock's recent return profile is mixed, with a 7 day return of 9.5% decline, a 30 day return of 18.1% decline, and a year to date return of 33.6% decline, set against a 1 year return of 37.6% decline and longer term 3 year and 5 year returns of 26.6% and 61.2% respectively. Recent headlines...

HubSpot (HUBS) was recently added to the NASDAQ Internet Index, a move that can expand its visibility with institutional investors and index trackers who reference or replicate that benchmark. See our latest analysis for HubSpot. The latest index inclusion comes after a tough stretch for the stock, with a 90 day share price return of 41.4% and a 1 year total shareholder return of 58.4%. This signals fading momentum despite the short term 3.0% daily gain to US$237.81. If this kind of sector...

If you are wondering whether Ondas at US$8.15 offers good value or too much excitement, you are not alone. The stock has seen a sharp 25.2% decline over the last week and a 26.0% decline year to date, even after delivering a very large 1 year return of 661.7% and a roughly 7x gain over 3 years. Recent coverage has focused on Ondas as a high volatility tech name where sentiment can shift quickly, and the share price moves reflect changing views on both its potential and its risks. That mix of...

Oracle (NYSE:ORCL) has launched NetSuite Restaurant Operations, an AI powered business system for global restaurant chains. The platform unifies key back office functions and is being localized for over 110 countries, 190 currencies, and 27 languages. The launch targets a large, fragmented restaurant sector and adds a new vertical focus to Oracle's cloud and AI offerings. For investors watching NYSE:ORCL at a share price of $138.8, this launch adds a fresh angle to the story around Oracle's...

Insiders who acquired US$5.09m worth of NovaBridge Biosciences' ( NASDAQ:NBP ) stock at an average price of US$3.89 in...

With no single headline event driving attention today, ZoomInfo Technologies (GTM) is drawing interest as investors weigh its recent share performance against reported revenue of US$1,249.5m and net income of US$124.2m. See our latest analysis for ZoomInfo Technologies. The recent 4.37% 1 day share price return to US$5.97 comes after a tougher stretch, with the 90 day share price return of 40.48% and 1 year total shareholder return of 40.30% pointing to fading momentum despite the current...